Clinical Trial

CAN1012 in Pre-malignant Oral Dysplasia

Name: CAN1012 in Pre-malignant Oral Dysplasia — clinical trial record (NCT07620496)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The primary objective of this trial is to examine the safety of CAN1012 delivered by intralesional injection ahead of planned surgical resection.

Trial Details

NCT Number	NCT07620496
Lead Sponsor	Providence Health & Services Collaborators: CanWell Pharma Inc.
Conditions	Oral Epithelial Dysplasia (OED)
Enrollment	36 participants
Start Date	2026-07-01
Primary Completion	2031-07 (estimated)
Study Completion	2033-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-02